NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery

New prostate cancer drug can extend life expectancy by 8 months, Baton Rouge doctor says

Pluvicto was recently approved by the FDA for men whose prostate cancer has not responded to standard treatments. It works by finding and attacking cancer cells while leaving healthy cells alone, which can mean better results and fewer side effects. Dr. William Russell in Baton Rouge brings the treatment to patients in Baton Rouge.

Randox Topham Chase race title to promote Prostate Cancer UK - Racing Together

The 2025 Randox Grand National Festival will take a significant step in raising awareness for prostate cancer, as the renowned Topham Chase on Ladies Day is officially named the Randox Supports Prostate Cancer UK Topham Chase. This initiative highlights the festival’s commitment to promoting vital health causes while celebrating the thrilling spectacle of jump racing. With prostate cancer affecting thousands of people in the UK each year, the pa…

NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.